Tricia Samaniego Martinez currently serves as a Senior Advisor for the Office of Biological Products Operations (OBPO), Immediate Office, within the Office of Regulatory Affairs for FDA. After receiving her Bachelor of Science in Microbiology from Texas A&M University, she joined the FDA as an Investigator. She has worked in the Houston and San Antonio offices conducting inspections and investigations in the Biologics, Human and Animal Drug, and Bioresearch Monitoring programs, in both the domestic and foreign arenas. Tricia most recently served as the Division Director of Investigations where she was responsible for leading a team of managers and investigators, primarily located in the western half of the US, during a time of quickly evolving technologies in the biologics industry. The staff under her management conducted inspections and investigations of establishments handling biological products, including blood and blood components, Source Plasma, and human cell, tissue, and cellular based tissue products. As a Senior Advisor, she is responsible for working directly with OBPO, as well as cross-organizational, leadership in developing, recommending, and coordinating operational priorities, activities and resources to ensure consistency and optimization throughout the program. In addition, she is responsible for leading multiple trainings, representing OBPO on Agency level work groups and advising OBPO leadership on emerging and precedent-setting issues.